Prospects not looking good yet The number of people who were tested for SARS-CoV-2 increased by 20% last week. The number of people who tested positive rose by 7%. The reproduction number also rose above 1.
Policy on coronavirus measures causes friction, but compliance is still high for now Compliance with the coronavirus measures in the Netherlands, such as the night-time curfew, working from home and avoiding crowds, is still high.
Decrease in meningococcal disease, outbreak of parrot fever in 2019 In the State of Infectious Diseases, RIVM provides an annual overview of the most important developments in relation to infectious diseases in the Netherlands.
Patient with novel coronavirus COVID-19 in the Netherlands A patient in the Netherlands was diagnosed with the novel coronavirus (COVID-19). Tests confirmed this today.
German coronavirus patient not sick during stay in Limburg On Tuesday evening 25 February, it was announced that a German man was tested positive for COVID-19. He would have been in the Netherlands last week.
Mesh implants intended to treat pelvic organ prolapse Synthetic mesh are used to treat patients with pelvic organ prolapse.
First results Plastic Pact Netherlands The Dutch Plastic Pact (Plastic Pact NL) was launched in the Netherlands in February 2019, and it is the first step to make single-use plastic products and packaging more sustainable and suitable f
Mental care still the most expensive of all In 2011, 19.6 billion euros was spent on the treatment of mental disorders. This amounted to 22% of the total expenditure on health and welfare during that year.
Risks of eHealth technology RIVM and Nictiz have made an overview of the risks that eHealth applications may entail and how these risks can be controlled.
Key organisations unite to improve benefit and risk assessments of vaccines Leading organisations have joined forces to launch a unique project that will pave the way for a pan-European framework for rapidly assessing and communicating the benefits and risks of vaccines.